Literature DB >> 19410954

Comparing retinal thickness measurements using automated fast macular thickness map versus six-radial line scans with manual measurements.

Mehran Taban1, Sumit Sharma, Dawn R Williams, Nadia Waheed, Peter K Kaiser.   

Abstract

PURPOSE: To compare automated retinal thickness values generated by the fast macular thickness maps (FMTM) and customized 6-radial line scans (RLS) versus manual retinal measurements on Stratus optical coherence tomography (OCT) (Carl Zeiss Meditec, Dublin, CA).
DESIGN: Prospective, observational case series. PARTICIPANTS: Patients with subfoveal choroidal neovascularization (CNV) caused by age-related macular degeneration (AMD), diabetic macular edema (DME), or branch/central retinal vein occlusion (RVO).
METHODS: Patients were prospectively imaged using the FMTM and customized RLS patterns on Stratus OCT at the same sitting. Each scan was evaluated for errors in retinal segmentation (i.e., correct retinal boundaries [CRB]). Automated values were recorded while central retinal thickness measurements were determined manually for both patterns. The presence or absence of epiretinal phenomenon, cystoid spaces, pigment epithelial detachment, and subretinal fluid was also noted. MAIN OUTCOME MEASURES: Errors in retinal segmentation at and outside the fovea (i.e., CRB) and percentage of automated values within a clinically acceptable margin (+/-25 mum) of the manual central retinal thickness.
RESULTS: A total of 147 eyes of 147 patients (95 eyes with exudative AMD, 41 eyes with DME, and 11 eyes with macular edema caused by RVO) were included. For wet AMD, the total number of CRB at the fovea and outside the fovea was 363 (63.7%) and 360 (63.2%), respectively, in FMTM and 428 (75.1%) and 426 (74.7%), respectively, in RLS (P<0.0001 for both). For DME and RVO, the total number of CRB at the fovea and outside the fovea was 274 (87.8%) and 256 (82.1%), respectively, in FMTM and 287 (92.0%) and 270 (86.5%), respectively, in RLS (P = 0.11, P = 0.15, respectively). Some 40% and 56% of automated foveal center point thicknesses on FMTM and RLS, respectively, were within +/-25 mum of the manual central retinal thickness for AMD (P = 0.042), versus 94% and 81% for DME and RVO, respectively (P = 0.07).
CONCLUSIONS: For exudative AMD, the RLS protocol provides fewer segmentation errors than the FMTM protocol, and its automated retinal thickness values (e.g., foveal center point, central subfield) correlate better with manual retinal thickness measurement than FMTM. In DME and RVO, however, both protocols provide similar and low segmentation errors, and their automated results are close to manual measurements. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

Entities:  

Mesh:

Year:  2009        PMID: 19410954     DOI: 10.1016/j.ophtha.2008.12.033

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

1.  Comparability of retinal thickness measurements using different scanning protocols on spectral-domain optical coherence tomography.

Authors:  Milton C Chew; Louis W Lim; Eujin Tan; Colin S Tan
Journal:  Int Ophthalmol       Date:  2016-02-18       Impact factor: 2.031

2.  Comparison between two multimodal imaging platforms: Nidek Mirante and Heidelberg Spectralis.

Authors:  Kimberly Spooner; Long Phan; Mariano Cozzi; Thomas Hong; Giovanni Staurenghi; Eugenia Chu; Andrew A Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-06       Impact factor: 3.117

3.  Efficacy and safety of a fixed bimonthly ranibizumab treatment regimen in eyes with neovascular age-related macular degeneration: results from the RABIMO trial.

Authors:  Nicolas Feltgen; Thomas Bertelmann; Mirko Bretag; Sebastian Pfeiffer; Reinhard Hilgers; Josep Callizo; Lena Goldammer; Sebastian Bemme; Hans Hoerauf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-01-19       Impact factor: 3.117

4.  Bevacizumab versus bevacizumab and macular grid photocoagulation for macular edema in eyes with non-ischemic branch retinal vein occlusion: results from a prospective randomized study.

Authors:  Josep Callizo; Abed Atili; Nina Antonia Striebe; Sebastian Bemme; Nicolas Feltgen; Hans Hoerauf; Thomas Bertelmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-04       Impact factor: 3.117

5.  COMPARISON OF SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY SCAN PATTERNS AND CLINICAL REVIEW STRATEGIES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Authors:  Robert J Courtney; Jedediah I McClintic; Justis P Ehlers
Journal:  Retina       Date:  2015-07       Impact factor: 4.256

6.  Optical coherence tomography-based decision making in exudative age-related macular degeneration: comparison of time- vs spectral-domain devices.

Authors:  C Cukras; Y D Wang; C B Meyerle; F Forooghian; E Y Chew; W T Wong
Journal:  Eye (Lond)       Date:  2009-08-21       Impact factor: 3.775

7.  Reading Center Characterization of Central Retinal Vein Occlusion Using Optical Coherence Tomography During the COPERNICUS Trial.

Authors:  Francis Char Decroos; Sandra S Stinnett; Cynthia S Heydary; Russell E Burns; Glenn J Jaffe
Journal:  Transl Vis Sci Technol       Date:  2013-12-23       Impact factor: 3.283

Review 8.  RETINAL FLUID AND THICKNESS AS MEASURES OF DISEASE ACTIVITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Authors:  Peter K Kaiser; Charles C Wykoff; Rishi P Singh; Arshad M Khanani; Diana V Do; Hersh Patel; Nikhil Patel
Journal:  Retina       Date:  2021-08-01       Impact factor: 3.975

9.  Thickness mapping of eleven retinal layers segmented using the diffusion maps method in normal eyes.

Authors:  Raheleh Kafieh; Hossein Rabbani; Fedra Hajizadeh; Michael D Abramoff; Milan Sonka
Journal:  J Ophthalmol       Date:  2015-04-19       Impact factor: 1.909

10.  Comparison of OCT Angiography Review Strategies to Identify Vascular Abnormalities in the AVATAR Study.

Authors:  Amy S Babiuch; Mehnaz Khan; Ming Hu; Peter K Kaiser; Sunil K Srivastava; Rishi P Singh; Allison Watts; Jamie L Reese; Justis P Ehlers
Journal:  Ophthalmol Retina       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.